Navigation Links
IMPAKT Breast Cancer Conference press program
Date:5/6/2010

Press releases (embargo: 6 May, 16:45 CEST)

J. Hicks, USA
Genome breakthrough allows scientists to identify and profile tumor cells from very small samples
Researchers have developed a powerful new technique for analyzing the genome of single tumor cells. The breakthrough allows them to study in fine detail the biology of how tumors develop.

S. Loi, BE
Estrogen receptor status of HER2+ breast cancer correlates with response to anti-HER therapies
An international team of researchers has discovered molecular evidence that may explain why some women with HER2 over-expressing breast cancer do not respond to drugs designed to target this important molecule.

B. Haine-Kains, USA
Simple gene test identifies clinically important sub-types of breast cancer
A simple genetic test that uses just three genes is among the most effective means of classifying breast cancer into sub-types.

A. Giordano, USA
Survival in metastatic breast cancer directly linked to circulating tumor cells
A new study of metastatic breast cancer shows that the number of circulating tumor cells patients have in their blood directly correlates with the length of their survival.

The full conference program is available at http://www.esmo.org/events/breast-2010-impakt/program.html

Press conference

Thursday, 06/05 at 12:00-13:00 (CEST)

Hosts:
Dr Martine Piccart, Head of Chemotherapy Unit, Jules Bordet Institute in Brussels, IMPAKT Co-Founder
Dr Angelo Di Leo, Head of Medical Oncology Unit, Department of Oncology, Hospital of Prato, Italy, IMPAKT2010 Co-Chair
Dr Christos Sotiriou, Head of Functional Genomics & Translational Research Unit, Jules Bordet Institute in Brussels, IMPAKT2010 Co-Chair

Topics:

  • The impact of methodology in biomarkers research and validation
  • Translational research impact on the next decade
  • Impact of neo-adjuvant trial results in the future treatment practice


'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. Estrogen receptor status of HER2+ breast cancer correlates with response to anti-HER therapies
2. Simple gene test identifies clinically important subtypes of breast cancer
3. Survival in metastatic breast cancer directly linked to circulating tumor cells
4. Breast cancer metastasis increases after estrogen and progestin hormone therapies, MU study finds
5. Broccoli May Help Battle Breast Cancer
6. Edgy, Sassy And Informative: New Website for Breast Cancer Survivors To Get Real About Their 'New Normal'
7. Whole body MRI is highly accurate in the early detection of breast cancer metastases
8. PMH cancer researchers link ovarian hormone to breast stem cells growth
9. Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research
10. Aggressive Action Urged When Evaluating Breast Lesions
11. Indeterminate breast lesions found in high-risk patients should be evaluated aggressively to exclude malignancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Pro X users can now reveal the media of their split screens with ...
(Date:6/27/2016)... , ... June 27, 2016 , ... TopConsumerReviews.com recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... -- In a startling report released today, National Safety Council ... comprehensive, proven plan to eliminate prescription opioid overdoses. Prescription ... are tackling the worst drug crisis in recorded U.S. history, assigned ... Kentucky , New Mexico , ... 28 failing states, three – Michigan , ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: